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OBJECTIVE—The potassium voltage-gated channel, KQT-like
subfamily, member 1 (KCNQ1) has been found through a ge-
nome-wide association study to be a strong candidate for con-
ferring susceptibility to type 2 diabetes in East Asian and
European populations. Our objective was to describe the asso-
ciation between polymorphisms at the KCNQ1 locus with insulin
resistance, -cell function, and other type 2 diabetes–related
traits in a sample of Chinese, Malays, and Asian Indians living in
Singapore.
RESEARCH DESIGN AND METHODS—We examined the
associations between four previously reported KCNQ1 single-
nucleotide polymorphisms (SNPs) with type 2 diabetes–related
traits in 3,734 participants from the population-based 1998 Sin-
gapore National Health Survey cohort (2,520 Chinese, 693 Malay,
and 521 Asian Indians). Insulin resistance was calculated from
fasting insulin and glucose using the homeostasis model assess-
ment method, whereas pancreatic -cell function was assessed
using the corrected insulin response at 120 min (CIR120).
RESULTS—SNPs rs2237897, rs2237892, and rs2283228 were
signiﬁcantly associated with type 2 diabetes (odds ratio [OR]
1.48, P  3  10
4; OR 1.38, P  0.002; OR 1.31, P  0.012,
respectively). Within the Chinese population, the risk alleles for
rs2237897, rs2237892, and rs2283228 were signiﬁcantly associ-
ated with higher fasting glucose levels (P  0.014, 0.011, and
0.034, respectively) and reduced CIR120 (P  0.007, 0.013, and
0.014, respectively). A similar trend was observed among the
Malay and Asian Indian minority groups, although this did not
reach statistical signiﬁcance because of limited sample sizes.
CONCLUSIONS—The increased risk for type 2 diabetes asso-
ciated with KCNQ1 is likely to be caused by a reduction in insulin
secretion. Further studies will be useful to replicate these
ﬁndings and to fully delineate the role of KCNQ1 and its related
pathways in disease pathogenesis. Diabetes 58:1445–1449,
2009
T
he prevalence of type 2 diabetes has increased
dramatically over the last 2 decades and is
predicted to double in a generation from 150
million in 2000 to 300 million by 2025 (1). The
majority of this increase is taking place in developing
countries undergoing nutritional transition and has a ma-
jor impact on morbidity and health care resources (2,3).
Although the precise pathophysiology of type 2 diabetes
remains unclear, it is largely thought to be caused by a
combination of the interaction between multiple genes
and environmental factors (4).
Single-nucleotide polymorphism (SNP) analysis of ge-
nome variation in large cohorts have led to the identiﬁca-
tion of several genes being implicated in the pathogenesis
of type 2 diabetes, of which TCF7L2 has been considered
to be the most important to date (5). More recently, the
ﬁrst genome-wide association study using 207,097 SNP
markers in Asian (Japanese) patients with type 2 diabetes
and unrelated control subjects was conducted. This led to
the ﬁnding that polymorphisms (rs2237895, rs2237897, and
rs2283228) within a novel diabetes susceptibility gene,
KCNQ1, were strongly associated with type 2 diabetes in
the Japanese population (6,7). Importantly, both studies
corroborated these novel ﬁndings in populations of Euro-
pean and East Asian ancestry, including Chinese subjects
living in Singapore (6). Notwithstanding these promising
ﬁndings, it is unclear whether these polymorphisms are
associated with quantitative traits relevant to the patho-
genesis of type 2 diabetes, primarily impaired -cell func-
tion and insulin resistance (8). Unoki et al. (6) did not
report any association with -cell function or insulin
resistance, whereas only Yasuda et al. (7) found an asso-
ciation with -cell function in Japanese (P  0.021) and
Finnish subjects (P  0.024). To ﬁll this knowledge gap,
we aimed to investigate the association of these polymor-
phisms with 1) insulin resistance and -cell function and
2) other quantitative metabolic risk phenotypes associated
with type 2 diabetes within three different ethnicities
(Chinese, Malay, and Asian Indian) living in Singapore.
RESEARCH DESIGN AND METHODS
The study used data from the cross-sectional population-based 1998 Singapore
National Health Survey (NHS98; n  4,723). Genotype data were available for
3,734 subjects comprising 2,520 Chinese, 693 Malay, and 521 Asian Indians. A
total of 1,881 Chinese subjects with normal glucose tolerance (NGT) had
previously served as the control subjects for the Singapore replication arm in
our original report (6), whereas type 2 diabetes case subjects were from a
separate study (the Singapore Diabetes Cohort Study). In this present study,
all subjects (including subjects with NGT, impaired fasting glucose, impaired
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DIABETES, VOL. 58, JUNE 2009 1445glucose tolerance [IGT], and type 2 diabetes) were derived from the NHS98
study. Details of the NHS98 survey have been previously described in greater
detail (9). Brieﬂy, this was a population-based, cross-sectional survey con-
ducted between September and November in 1998. The reference population
was 2.16 million Chinese, Malay, and Asian Indian Singapore residents aged
between 18 and 69 years. The survey was based on the World Health
Organization (WHO)-recommended model for ﬁeld surveys of diabetes and
other noncommunicable diseases and the WHO MONICA protocol for popu-
lation surveys. The research protocol for NHS98 was approved by the
Singapore General Hospital Institutional Review Board (#54/2001).
Biological measures. Fasting blood samples were collected for glucose and
insulin after an overnight fast of 10 h. All subjects underwent a 75-g oral
glucose tolerance test except those taking oral hypoglycemic agents or
insulin. Subjects were classiﬁed as having diabetes if they gave a history of
diabetes or if their fasting glucose was 7 mmol/l or 2-h post-challenge
glucose 11.1 mmol/l. Impaired fasting glycemia was deﬁned as fasting glucose of
6–7 mmol/l and impaired glucose tolerance as 2-h post-challenge glucose of
7.8–11.1 mmol/l. Other measurements included the following: BMI and waist and
hip circumference. Insulin resistance was estimated using the homeostasis model
assessment method (HOMA-IR) (10). -Cell function was assessed using the
corrected insulin response at 120 min (CIR120) (11).
SNP genotyping. Genotyping of four SNPs in intron 15 of KCNQ1 rs2237897
(cT), rs2237895 (AC), rs2237892 (CT), and rs2283228 (AC) was per-
formed using the TaqMan SNP genotyping assay (Applied Biosystems, Foster
City, CA). Genotyping success rate for rs2237897, rs2237895, rs2237892, and
rs2283228 was 92, 99, 92, and 87%, respectively. To assess reproducibility, 1%
of samples were analyzed in duplicate; genotyping was 100% concordant for
these samples.
Statistical analysis. Minor allele frequency, Hardy-Weinberg equilibrium,
and linkage disequilibrium (LD; reported using r
2) were estimated using
Haploview (12). The distribution of glucose and insulin measures were
skewed and therefore normalized by natural logarithmic transformation.
Means were subsequently back transformed for presentation. Quantitative
traits are presented as means and SDs. Linear regression analyses were
performed to study the associations between diabetes-related traits with
genotypic groups. Individuals were as assigned as 0/1/2 according to their
number of minor alleles under an additive model of inheritance. There was no
signiﬁcant heterogeneity between the sexes (P  0.05), and subsequent
analyses were performed with the sexes combined and adjusted for sex.
Linear regression with adjustment for ethnicity was used to estimate the
summary effect size of the SNPs in the combined sample from the three ethnic
groups. Logistic regression was used to estimate the association between
KCNQ1 SNPs and type 2 diabetes. All analyses were stratiﬁed by ethnic group
and adjusted for age, sex, and BMI (where appropriate). Analysis of associa-
tion with -cell function was further adjusted for insulin resistance (13).
Analyses were performed using STATA (version 9.1 for Windows) (14).
RESULTS
The anthropometric and biochemical characteristics of the
participants are detailed in Table 1. Among these individ-
uals, there was a higher prevalence of type 2 diabetes
among the Malay and Asian Indian populations and a
lower mean BMI and fasting glucose level among the
Chinese population.
Allele frequency for rs2237897, rs2237895, rs2237892,
and rs2283228 were similar between the Chinese and
Malays but different in Asian Indians (Table 2). rs2237895
was in weak LD with rs2237897, rs2237892, and rs2283228
(r
2  0.25), whereas moderate LD was observed between
rs2237897, rs2237892, and rs2283228 (Chinese: r
2  0.56–
0.79 Malay: r
2  0.74–0.86, Asian Indian: r
2  0.39–0.62)
(Supplemental Fig. 1, found in an online-only appendix
at http://diabetes.diabetesjournals.org/cgi/content/full/db08-
1138/DC1). All SNPs in the Chinese and Malays were in
Hardy-Weinberg equilibrium (P  0.05). In the Asian Indians,
TABLE 1
Clinical characteristics of the NHS98 study population by ethnicity
Chinese Malay Asian Indian
n 2,520 693 521
Age 37.9  12.2 38.8  12.7 40.5  12
% male 54.5 52.4 52.5
BMI (kg/m
2) 22.7  3.7 25.6  5 25.2  4.8
Waist-to-hip ratio 0.82  0.07 0.83  0.08 0.86  0.08
Waist circumference (cm) 78.1  10.6 82.6  12 85.2  11.8
Fasting glucose (mmol/l)*† 5.53 (0–17.9) 5.89 (3.5–30) 6.01 (4.1–21.5)
Fasting insulin (mmol/l)*† 6.13 (0.2–576) 7.38 (0.7–83.4) 8.81 (1–119)
HOMA-IR*† 1.47 (0.05–19.68) 1.86 (0.11–22.24) 2.2 (0.23–31.2)
CIR120*† 0.79 (0.001–9.2) 0.76 (0.002–10.9) 0.84 (0.003–11.1)
Glucose tolerance (%)
NGT 75.2 60 60.7
IFG/IGT 17.2 25.6 19.9
Type 2 diabetes 7.6 14.4 19.4
Data are means  SD unless otherwise stated. CIR120: 100  I120/G120  (G120  70)	. Units for insulin120 (I
120) are given in mmol/l and for
glucose120 (G120) in mg/dl. *Geometric mean (range) shown, due to skewed nature of data. †Subjects taking diabetes medication were
excluded (59 Chinese, 35 Malays, and 44 Asian Indians).
TABLE 2
Association of KCNQ1 genetic variants with type 2 diabetes in
the Chinese, Malay, and Asian Indian population in Singapore
Risk allele
frequency OR (95% CI) P*
rs2237897 (CT)
Chinese 0.65 1.50 (1.15–1.96) 0.003
Malay 0.67 1.32 (0.88–1.98) 0.183
Asian Indians 0.95 2.61 (1.01–6.74) 0.047
Combined 1.48 (1.20–1.83) 3  10
4
rs2237895 (AC)
Chinese 0.35 1.09 (0.85–1.39) 0.496
Malay 0.32 1.39 (0.90–2.14) 0.14
Asian Indians 0.39 1.17 (0.81–1.70) 0.394
Combined 1.16 (0.97–1.4) 0.111
rs2237892 (CT)
Chinese 0.67 1.39 (1.08–1.79) 0.011
Malay 0.68 1.28 (0.85–1.93) 0.245
Asian Indians 0.95 2.32 (0.87–6.22) 0.094
Combined 1.38 (1.12–1.70) 0.002
rs2283228 (AC)
Chinese 0.63 1.22 (0.94–1.58) 0.135
Malay 0.66 1.39 (0.91–2.11) 0.124
Asian Indians 0.92 2.16 (0.98–4.74) 0.055
Combined 1.31 (1.06–1.61) 0.012
Risk allele denoted in bold. *P values adjusted for age, sex, BMI, and
ethnicity (for combined analysis).
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(rs2237897, rs2237892, and rs2283228) were not in the Hardy-
Weinberg equilibrium. Consequently, the results for the Asian
Indians should be interpreted with caution.
Table 2 shows the association between KCNQ1 SNPs
with type 2 diabetes in the Chinese, Malay, and Asian
Indian population in Singapore. Signiﬁcant associations
were observed in the Chinese, with rs2237897 showing the
strongest effect: odds ratio (OR) 1.50 (1.15–1.96), P 
0.003. In the combined sample of the three ethnic groups,
the risk alleles of rs2237897 (C), rs2237892 (C), and
rs2283228 (A) were also associated with type 2 diabetes in
our study, consistent with previous reports (6,7). Of these,
rs2237897 showed the strongest association (OR 1.48
[1.20–1.83], P  0.0003). In the combined sample of only
Chinese and Malays subjects, the association with
rs2237897 remained signiﬁcant (OR 1.45 [1.16–1.81], P 
0.001).
Table 3 shows the association between KCNQ1 SNPs
with diabetes-related traits. The risk alleles for rs2237897,
rs2237892, and rs2283228 showed statistically signiﬁcant
association with higher fasting glucose levels (P  0.014,
0.011, and 0.034, respectively) and reduced CIR120 (P 
0.007, 0.013, and 0.014, respectively) in the Chinese popu-
lation. After restricting to subjects without diabetes, the
association remained signiﬁcant with CIR120 (P  0.011,
0.020, and 0.015, respectively; online appendix Table 1). A
similar trend was observed among the Malays and Asian
Indians, although the associations did not reach statistical
signiﬁcance, possibly because of the limited sample sizes
for these minority ethnic groups. In the combined analysis,
rs2237897 and rs2237892 were signiﬁcantly associated
with fasting glucose levels (P  0.029 and P  0.021,
respectively), whereas rs2237897, rs2237892, and rs2283228
were signiﬁcantly associated with lower -cell function
(CIR120)( P  0.013, 0.021, and 0.020, respectively). These
SNPs also showed associations with BMI in the Malay
population and waist-to-hip ratio in Asian Indians. How-
ever, these associations were no longer statistically signif-
icant in the combined analysis. Based on a risk allele
frequency of between 0.3 and 0.6, power calculations
estimate that the combined sample provided 90% power to
detect a 10% change in the examined traits.
DISCUSSION
Polymorphisms within KCNQ1 have recently been shown
to be strongly associated with an increased risk of type 2
diabetes in the East Asian and European populations (6,7).
Of the three polymorphisms within KCNQ1 previously
described, rs2237897 appeared to have the strongest asso-
ciation with type 2 diabetes (6), whereas another study
reported the strongest association with rs2237892 (7).
Consistent with these ﬁndings, we found that both these
SNPs were signiﬁcantly associated with type 2 diabetes in
the combined analysis of three ethnic groups. In addition,
the presence of the risk allele for KCNQ1 variants
rs2237897, rs2237892, and rs2283228 were associated with
increased fasting glucose level and decreased -cell func-
tion in the Chinese population and combined sample. This
is in agreement with the study by Yasuda et al. (7), which
reported an association of these KCNQ1 variants with
-cell function. Together, these ﬁndings corroborate the
hypothesis that the role of this protein in the pathogenesis
of type 2 diabetes is likely mediated through its effects on
the pancreatic -cell, although there is still a possibility
that these polymorphisms may increase the risk of type 2
diabetes through regulation of nearby genes. In contrast,
there was no association between rs2237895 with any
diabetes-related traits, speciﬁcally highlighting the impor-
tance of the polymorphisms rs2237897, rs2237892, and
rs2283228 (which are in moderate LD) in increasing the
risk of developing type 2 diabetes. Further ﬁne mapping of
SNPs in KCNQ1, especially within the LD block containing
rs2237897 and rs2237892, may allow the identiﬁcation of
the causal variant.
KCNQ1 is located on 11p15.5, which encodes the pore-
forming 
-subunit of the IKSK
 channel, which is ex-
pressed mainly in the heart and, to a lesser extent, the
inner ear, stomach, small and large intestine, liver, and
kidney. KCNQ1 is also expressed in the pancreas, where it
is coexpressed with products of other regulators such as
KCNE1, which may alter its biophysical characteristics
and role (15). As such, it is plausible that polymorphisms
within the KCNQ1 gene alter the properties and role of
the IKSK
 channel, causing decreased pancreatic -cell
function and insulin production, leading eventually to
hyperglycemia.
Whereas we do appreciate that the associations ob-
served in the Chinese do not represent an independent
replication, since the controls used are largely the same as
those in the study by Unoki et al. (6), we have provided
data on Malays and Indians and, in our opinion, it was
reassuring that similar trends for an effect of these three
polymorphisms on association with type 2 diabetes, fast-
ing glucose, and -cell function were also observed in the
Malay and Asian Indian subjects, even though their limited
numbers certainly resulted in a reduction of study power.
Although associations with BMI in Malays and waist-to-hip
ratio in Asian Indians were found, the smaller sample sizes
for these ethnic groups, together with the fact that these
observations were not found in other ethnic groups,
inevitably led us to be cautious in interpreting these
ﬁndings. One caveat of this study is that we only examined
the SNPs, which showed the strongest association, identi-
ﬁed by Unoki et al. (6) and Yasuda et al. (7). Although the
Chinese show strong and consistent associations with
these SNPs, the association among Malays and Asian
Indians is less clear. Further ﬁne mapping of the KCNQ1
locus, for instance, through deep DNA resequencing may
allow the identiﬁcation of population-speciﬁc causative
variants.
The use of CIR120 represented a limitation of our study,
since it only served as an approximate measure of -cell
function, which may be better assessed using the CIR30.
Thus, if CIR30 measurements were available, the positive
associations that had been observed in our study may be
further strengthened. It has also been suggested that
CIR120 could inadvertently capture information on addi-
tional aspects of glucose intolerance instead of insulin
secretion alone. The previous ﬁnding of the association
between CIR30 with KCNQ1 SNPs, in nondiabetic Euro-
pean subjects of the Botnia prospective study during their
follow-up visit (P  0.024) (7), however, appeared to
corroborate our hypothesis that these SNPs may exert
their effect on type 2 diabetes through an effect on insulin
secretion.
In conclusion, the risk alleles of rs2237897, rs2237892,
and rs2283228 within the KCNQ1 gene are associated with
decreased pancreatic -cell function and fasting glucose
levels, suggesting that the impact of these polymorphisms
on the risk of type 2 diabetes may be mediated through an
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SNPs IN KCNQ1 AND TYPE 2 DIABETES IN CHINESE
1448 DIABETES, VOL. 58, JUNE 2009impact on -cell function rather than insulin resistance.
Further studies will be useful to replicate these promising
ﬁndings and to fully delineate the role of KCNQ1 and its
related pathways in the pathogenesis of type 2 diabetes.
ACKNOWLEDGMENTS
This work was funded by the Singapore National Medical
Research Council (NMRC/1115/2007).
No potential conﬂicts of interest relevant to this article
were reported.
REFERENCES
1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the
diabetes epidemic. Nature 2001;414:782–787
2. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY.
Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681–1688
3. Soderberg S, Zimmet P, Tuomilehto J, de Courten M, Dowse GK, Chitson
P, Stenlund H, Gareeboo H, Alberti KG, Shaw J. High incidence of type 2
diabetes and increasing conversion rates from impaired fasting glucose
and impaired glucose tolerance to diabetes in Mauritius. J Intern Med
2004;256:37–47
4. O’Rahilly S, Barroso I, Wareham NJ. Genetic factors in type 2 diabetes: the
end of the beginning? Science 2005;307:370–373
5. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A,
Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkars-
dottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gud-
mundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP,
Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thor-
steinsdottir U, Gulcher JR, Kong A, Stefansson K. Variant of transcription
factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet
2006;38:320–323
6. Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, Andersen G, Ng
DP, Holmkvist J, Borch-Johnsen K, Jorgensen T, Sandbaek A, Lauritzen T,
Hansen T, Nurbaya S, Tsunoda T, Kubo M, Babazono T, Hirose H, Hayashi
M, Iwamoto Y, Kashiwagi A, Kaku K, Kawamori R, Tai ES, Pedersen O,
Kamatani N, Kadowaki T, Kikkawa R, Nakamura Y, Maeda S. SNPs in
KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian
and European populations. Nat Genet 2008;40:1098–1102
7. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, Hirota Y,
Mori H, Jonsson A, Sato Y, Yamagata K, Hinokio Y, Wang HY, Tanahashi T,
Nakamura N, Oka Y, Iwasaki N, Iwamoto Y, Yamada Y, Seino Y, Maegawa
H, Kashiwagi A, Takeda J, Maeda E, Shin HD, Cho YM, Park KS, Lee HK,
Ng MC, Ma RC, So WY, Chan JC, Lyssenko V, Tuomi T, Nilsson P, Groop
L, Kamatani N, Sekine A, Nakamura Y, Yamamoto K, Yoshida T, Tokunaga
K, Itakura M, Makino H, Nanjo K, Kadowaki T, Kasuga M. Variants in
KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat
Genet 2008;40:1092–1097
8. DeFronzo RA. Lilly Lecture 1987: The triumvirate: beta-cell, muscle, liver:
a collusion responsible for NIDDM. Diabetes 1988;37:667–687
9. Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in
Singapore following a national intervention programme. Bull World Health
Organ 2001;79:908–915
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner
RC. Homeostasis model assessment: insulin resistance and beta-cell func-
tion from fasting plasma glucose and insulin concentrations in man.
Diabetologia 1985;28:412–419
11. Sluiter WJ, Erkelens DW, Reitsma WD, Doorenbos H. Glucose tolerance
and insulin release, a mathematical approach I. Assay of the beta-cell
response after oral glucose loading. Diabetes 1976;25:241–244
12. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization
of LD and haplotype maps. Bioinformatics 2005;21:263–265
13. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling.
Diabetes Care 2004;27:1487–1495
14. Kamboh MI, Bunker CH, Aston CE, Nestlerode CS, McAllister AE, Ukoli
FA. Genetic association of ﬁve apolipoprotein polymorphisms with serum
lipoprotein-lipid levels in African blacks. Genet Epidemiol 1999;16:205–222
15. Warth R, Garcia Alzamora M, Kim JK, Zdebik A, Nitschke R, Bleich M,
Gerlach U, Barhanin J, Kim SJ. The role of KCNQ1/KCNE1 K() channels
in intestine and pancreas: lessons from the KCNE1 knockout mouse.
Pﬂugers Arch 2002;443:822–828
J.T. TAN AND ASSOCIATES
DIABETES, VOL. 58, JUNE 2009 1449